Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial ResultsBusiness Wire • Thursday
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial ResultsBusiness Wire • 07/30/26
Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual MeetingBusiness Wire • 05/21/26
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial ResultsBusiness Wire • 04/30/26
Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual MeetingBusiness Wire • 04/21/26
Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026Business Wire • 04/20/26
Wall Street Analysts Believe Bicycle Therapeutics (BCYC) Could Rally 137.88%: Here's is How to TradeZacks Investment Research • 04/16/26
After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Bicycle Therapeutics (BCYC)Zacks Investment Research • 03/24/26
Bicycle Therapeutics (BCYC) Loses 19.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 03/23/26
Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026Business Wire • 03/18/26
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial ResultsBusiness Wire • 03/17/26
Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology PipelineBusiness Wire • 02/03/26
Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026Business Wire • 01/12/26
Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical PipelineBusiness Wire • 12/16/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bicycle Therapeutics plc - BCYCPRNewsWire • 12/11/25
ATTENTION BCYC Investors: Securities Fraud Investigation Underway - Contact Levi & KorsinskyNewsfile Corp • 11/18/25
Bicycle Therapeutics to Participate in the Jefferies London Healthcare ConferenceBusiness Wire • 11/12/25
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial ResultsBusiness Wire • 10/30/25
Bicycle Therapeutics Plc (BCYC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/09/25
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial ResultsBusiness Wire • 08/08/25
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 07/02/25